Navigation Links
Dynamin drug discovery team win prestigious international epilepsy grant
Date:6/18/2008

A drug discovery and development collaboration between leading Australian Institutions, the Children's Medical Research Institute (CMRI), University of Newcastle, University of Melbourne and Bio-Link Partners Ltd., has been announced as the Epilepsy Therapy Project, June 2008 New Therapy Grant winners. This prestigious research grant recognises their promising drug discovery program, which is focussed on development and commercialisation of small molecule inhibitors of the GTPase Dynamin, a key component of the synaptic vesicle cycle and a novel approach to treatment of epilepsy.

The two year US$278,800 grant to the Dynamin Drug Discovery Program will support the refinement of lead classes of inhibitors which have demonstrated efficacy in animal models towards clinical development and commercialisation. The Dynamin Drug Discovery Program consists of leading expertise in synaptic vesicle endocytosis and dynamin biology, medicinal chemistry and translational studies in acquired epilepsy models. Award of the New Therapy Grant recognises the potential of dynamin as a new molecular target for the design of a new class of therapeutics to treat epilepsy. In announcing the award, Joyce Cramer, President of the Epilepsy Therapy Project said " The Australian group exemplifies the ideal of collaboration among experts to work on a novel approach to limiting seizure propagation. We are eager to watch their progress toward human studies that will reveal the full potential of this effect on brain signaling".

The Epilepsy Therapy Project seeks to advance the development of new therapies for epilepsy, including new medicines and therapeutic devices. The grants committee consists of leading opinion leaders in the fields of epilepsy clinical practice and anti-epileptic drug (AED) research. The Program attracts applications from leading research groups and biotech companies worldwide. Consistent with the theme of translational research, all grant proposals must
'/>"/>

Contact: Jens Tampe
j.tampe@bio-link.com
61-292-094-381
Research Australia
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research
2. New Molecule Discovery Shows Promise Against Tamoxifen-Resistant Breast Cancers
3. Stem cell discovery sheds light on placenta development
4. Discovery of new signal pathway important to diabetes research
5. Immtech Announces Results From Hepatitis C Discovery Program
6. Discovery of new family of genetic mutations involved in inflammatory intestinal disease
7. Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership
8. Spirus Medical Announces 510(k) Clearance from FDA for Expanded Use of Endo-Ease(R) Discovery SB(TM)
9. Discovery of cell linked to learning and memory
10. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
11. Discovery of a novel mechanism for the development of colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... in Cambridge have discovered that the loss of a key ... is the first study to show that this kind of ... in Nature . , The study, led by Dr ... Hurles from the Wellcome Trust Sanger Institute, looked at 300 ... entire genome looking for types of mutation known as copy ...
(Date:12/6/2009)... College of Wisconsin, in Milwaukee, found a substantial variation ... disease complications in children. Barriers to its use on ... identified. The study led by Amanda M. Brandow, ... College and Children,s Research Institute at the Children,s Hospital ... of Hematology meeting Dec. 7, 2009, in New Orleans. ...
(Date:12/6/2009)... clotting, or coagulation, is an important process that ... injured. Sometimes, however, clots form on the inside ... not dissolve naturally, a potentially life-threatening situation requiring ... Meeting of the American Society of Hematology reveals ... and heparin with the hope of preventing clots ...
(Date:12/6/2009)... with the Greater VA Healthcare System in West Los Angeles, will ... to soar to more than 5,000 veterans, active military personnel and ... ... 2009 -- Volunteer organizations and members of the community, in cooperation ... once again create a holiday party. This year,s attendance is expected ...
(Date:12/5/2009)... There have been significant scientific advances in the ... gain a better understanding of how certain diseases progress ... patients with the best care. Research presented today at ... Hematology explores optimal induction therapies for managing multiple myeloma, ...
Breaking Medicine News(10 mins):Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8
... LONG ISLAND, N.Y., Oct. 2 Suzanne Somers, ... some of Long Island,s most,brilliant, wellness oriented doctors ... 4th NAVEL Expo (Nutrition, Aesthetics, Vitality,Efficacy, Life ... ... the,fundamentals of weight loss, beauty, fitness, longevity, vitality ...
... recommendations that restrict women who have previously been pregnant ... impact on the blood supply. The reason is a ... Injury, or TRALI. According to the FDA, TRALI is ... and female patients. Pall Corporation (NYSE: PLL), a leading ...
... Fight Against Women,s ... Cancers, ... introduced in the U.S. House of,Representatives on Thursday, Sept. 27 and the ... legislation, is issuing a "call to action" for ovarian cancer,survivors, their families, ...
... System Up-Time and Improved Overall ... ... Diagnostics (http://www.siemens.com/diagnostics ) announced today,worldwide availability of version 2.0 ... software will be a required upgrade for,all existing customers and ...
... a Raleigh,dentist, will bicycle from Murphy to Manteo, N.C., Oct. ... the 6-day 750-mile solo ride, called "The Ride for Oral ... to call attention to the importance of annual oral cancer,exam," ... major European cycling events,was inspired to undertake the trek by ...
... MONTREAL, Oct. 2 /PRNewswire-FirstCall/ - Haemacure Corporation,(TSX:HAE), a ... Mr. Joseph Galli, Chairman and Chief Executive,Officer, will ... will be,speaking on Wednesday, October 3, 2007 at ... City. About BioContact Quebec 2007 BioContact ...
Other Medicine News:Health News:Healthy Weight Loss Begins With What You Permit to Enter Your Mind, More So Than Even Your Mouth! 2Health News:New transfusion rules restrict donations from previously pregnant women 2Health News:New transfusion rules restrict donations from previously pregnant women 3Health News:New Ovarian Cancer Biomarker Research Act Introduced 2Health News:New Ovarian Cancer Biomarker Research Act Introduced 3Health News:Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software 2Health News:Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software 3Health News:Raleigh Dentist to Bicycle Across North Carolina to Raise Oral Cancer Awareness 2Health News:Presentation at Bio Contact Quebec 2007 2
(Date:12/4/2009)... MARLTON, N.J., Dec. 4 Thermographic Diagnostic Imaging ... in Marlton, New Jersey continues to provide superior ... thyroid, dental, TMJ and sinus regions to assist ... these areas. ,, Thermography utilizes infrared imaging ...
(Date:12/4/2009)... Inc. (Nasdaq: ONXX ) today announced that it ... investigators will discuss the data presentations surrounding carfilzomib in ... 51st American Society of Hematology (ASH) Annual Meeting. ,, ... ET on Monday, December 7, 2009. The live ...
(Date:12/4/2009)... 4 PharmAthene, Inc. (NYSE Amex: PIP ), ... chemical threats, announced today the presentation of new data ... lyophilized recombinant Protective Antigen (rPA) based anthrax vaccine is ... temperatures up to and including 55 degrees C. ...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Lifeline Issues Safety Notice to Subscribers 56977 1Lifeline Issues Safety Notice to Subscribers 56977 2Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 1Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 2Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 3Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 4JHSPH to lead extremity trauma clinical research consortium 56974 1JHSPH to lead extremity trauma clinical research consortium 56974 2JHSPH to lead extremity trauma clinical research consortium 56974 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: